Boston Scientific Corp. Hits 52-Week Low at USD 50.05

Boston Scientific Corp. has reached a significant milestone by touching a new 52-week low of USD 50.05 on May 27, 2026. This marks a notable decline in the stock's performance, with a one-year decrease of 34.82%, contrasting sharply with the S&P 500's gain of 27.0% during the same period. As a large-cap company in the retailing industry, Boston Scientific boasts a market capitalization of approximately USD 121,935 million. The stock currently has a price-to-earnings (P/E) ratio of 36.00, indicating how the market values its earnings relative to its share price. The company maintains a debt-to-equity ratio of 0.39, reflecting a relatively low level of debt compared to its equity. Additionally, Boston Scientific has a return on equity of 13.88%, showcasing its efficiency in generating profits from shareholders' equity. Despite the recent price movement, the stock's performance metrics highlight its position within the market and the retailing sector.